A small study suggests that slowing deep brain stimulation down to 4 Hz may improve cognitive accuracy in some people with Parkinson’s, raising the possibility that future systems could target motor and cognitive symptoms differently.
Deep brain stimulation has been used for years to control the motor symptoms of Parkinson’s disease. But researchers are now asking whether changing how those electrical signals are delivered could also help with one of the disease’s most difficult non-motor problems: cognitive impairment.
In a small study of 17 people with Parkinson’s who already had subthalamic nucleus DBS, researchers found that stimulation delivered at a much lower frequency than is typically used improved performance on a test of cognitive control. Instead of the roughly 130-hertz stimulation commonly used for motor symptoms, they tested stimulation at just 4 Hz, a frequency within the brain’s theta range. According to the preprint posted on medRxiv, the results suggest something worth paying attention to: the frequency that works best for movement may not be the frequency that works best for thinking.
Turning DBS Down, Way Down
Deep brain stimulation works by surgically implanting electrodes into specific areas of the brain. In Parkinson’s disease, one common target is the subthalamic nucleus, or STN, a small structure deeply involved in the circuits that control movement. Electrical stimulation is then delivered through the electrodes, and traditional STN-DBS generally runs around 130 Hz, a frequency with a well-established ability to improve tremor, rigidity, slowness, and other motor symptoms.
The researchers behind this new study took a very different approach. They recruited 17 people with Parkinson’s, 10 with cognitive impairment and seven without, and evaluated each participant under three conditions: DBS turned off, conventional stimulation at approximately 130 Hz, and low-frequency stimulation at 4 Hz. Motor performance was measured using Part III of the MDS-UPDRS, while cognitive performance was tested using the Multi-Source Interference Task, which measures a person’s ability to resolve conflicting information and select the correct response.
Four Hertz Produced an Unexpected Result
For movement, conventional DBS still came out ahead. Motor function improved during 4-Hz stimulation compared with DBS turned off, but it improved further under conventional stimulation. Reaction times followed the same pattern, faster with 4 Hz than with no stimulation, and faster still under conventional high-frequency stimulation.
Accuracy told a different story. Four-hertz stimulation improved cognitive accuracy compared with both DBS turned off and conventional 130-Hz stimulation, according to the medRxiv preprint.
That distinction between speed and accuracy could matter. Cognitive control isn’t really about responding faster, it’s about the brain’s ability to suppress an automatic response, weigh competing information, and land on the correct decision. Earlier work from the same research group had already connected roughly 4-Hz brain activity with cognitive control in Parkinson’s, finding that people with Parkinson’s-related cognitive impairment often show diminished low-frequency activity over frontal regions of the brain, and that weaker activity tracks with poorer cognitive performance, per findings published in Nature. That earlier work raised an obvious next question: what happens if researchers stimulate the Parkinson’s brain at roughly that same frequency? This new study offers an early answer.
One Frequency for Movement, Another for Thinking?
The study points to a potentially important shift in where DBS technology could be headed. Current systems are built almost entirely around controlling motor symptoms, but Parkinson’s involves far more than movement. Cognitive impairment, sleep problems, depression, anxiety, and other non-motor symptoms can eventually matter as much to quality of life as tremor or rigidity.
Rather than treating DBS as a device that runs at one therapeutic setting, future systems might deliver different stimulation patterns for different symptoms, high frequency for motor problems, lower frequency when cognitive control is the priority. That fits with the broader push toward adaptive DBS, where implanted devices monitor brain activity and adjust stimulation in response to what’s actually happening in the brain, rather than delivering the same signal continuously.
A recent systematic review and meta-analysis points in the same direction. Looking across 43 studies of DBS frequency and cognition, researchers found that lower-frequency STN stimulation was associated with modest advantages in areas like verbal fluency and cognitive flexibility compared with high-frequency stimulation, though the evidence remains limited and inconsistent.
This Is Still a Very Small Study
As interesting as the results are, 17 participants is nowhere near enough to establish 4-Hz DBS as a treatment for cognitive impairment in Parkinson’s, and only 10 of those participants actually had cognitive impairment to begin with. The experiment also measured short-term performance on a single cognitive task, so it doesn’t tell us whether regular use of 4-Hz stimulation would improve memory, attention, executive function, or everyday cognitive ability over months or years. And conventional high-frequency DBS still worked better for motor symptoms.
Those limitations are exactly why larger, controlled studies are needed before this approach could become part of routine DBS programming. The study was first posted as a preprint in March 2026, so what’s available describes early experimental findings rather than evidence from a large clinical trial. It’s proof of concept, not a treatment recommendation.
A Different Way of Thinking About DBS
For decades, one of the biggest questions in deep brain stimulation has been where to stimulate. Increasingly, researchers are also asking when and how. Parkinson’s isn’t a single-symptom disease, and the electrical activity tied to tremor, slowness, gait problems, and cognition doesn’t necessarily occur at the same frequencies or involve the same networks.
If those signals can eventually be identified reliably, future DBS systems may be programmed less like a continuously running switch and more like a responsive neurological device, one that recognizes different brain states and adjusts accordingly. The 4-Hz findings are an early step in that direction.
For now, conventional high-frequency DBS remains the standard for treating Parkinson’s motor symptoms. But this small study suggests that buried within the same implanted system may be another therapeutic possibility: changing the rhythm of stimulation could change what DBS is capable of treating.
Discover more from
Subscribe to get the latest posts sent to your email.
